Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$13.39 USD
-0.01 (-0.07%)
Updated May 13, 2024 04:00 PM ET
After-Market: $13.48 +0.09 (0.67%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ASMB 13.39 -0.01(-0.07%)
Will ASMB be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ASMB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASMB
Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
TEVA Shares Rise on Broad Support for Opioids Settlement
ASMB: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging 17% in 4 Weeks, Here's Why the Trend Might Reverse for Assembly Biosciences (ASMB)
Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why
Best Momentum Stocks to Buy for August 4th
Other News for ASMB
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024
H.C. Wainwright Sticks to Its Hold Rating for Assembly Biosciences (ASMB)
Assembly Biosciences: Q1 Earnings Snapshot
Assembly Biosciences GAAP EPS of -$1.66 beats by $1.57, revenue of $5.79M
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights